PLSE logo

Pulse Biosciences (PLSE) Company Overview

Profile

Full Name:

Pulse Biosciences, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 18, 2016

Indexes:

Not included

Description:

Pulse Biosciences (PLSE) is a biotechnology company that develops innovative medical devices using a unique technology called Nano-Pulse Stimulation. This technology targets and treats various medical conditions, including cancer and skin disorders, by delivering precise energy pulses to cells, promoting healing and improving patient outcomes.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 21, 22 Maxim Group
Hold
May 13, 22 HC Wainwright & Co.
Neutral
Apr 1, 22 Stephens & Co.
Overweight
Apr 1, 22 HC Wainwright & Co.
Buy
Feb 10, 22 HC Wainwright & Co.
Buy
Nov 16, 21 HC Wainwright & Co.
Buy
Jul 27, 21 Stephens & Co.
Overweight
Mar 11, 21 Maxim Group
Buy
Jan 26, 21 HC Wainwright & Co.
Buy
May 12, 20 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Pulse Biosciences?
  • Does Pulse Biosciences pay dividends?
  • What sector is Pulse Biosciences in?
  • What industry is Pulse Biosciences in?
  • What country is Pulse Biosciences based in?
  • When did Pulse Biosciences go public?
  • Is Pulse Biosciences in the S&P 500?
  • Is Pulse Biosciences in the NASDAQ 100?
  • Is Pulse Biosciences in the Dow Jones?
  • When was Pulse Biosciences's last earnings report?
  • When does Pulse Biosciences report earnings?
  • Should I buy Pulse Biosciences stock now?

What is the ticker symbol for Pulse Biosciences?

The ticker symbol for Pulse Biosciences is NASDAQ:PLSE

Does Pulse Biosciences pay dividends?

No, Pulse Biosciences does not pay dividends

What sector is Pulse Biosciences in?

Pulse Biosciences is in the Healthcare sector

What industry is Pulse Biosciences in?

Pulse Biosciences is in the Medical Instruments & Supplies industry

What country is Pulse Biosciences based in?

Pulse Biosciences is headquartered in United States

When did Pulse Biosciences go public?

Pulse Biosciences's initial public offering (IPO) was on May 18, 2016

Is Pulse Biosciences in the S&P 500?

No, Pulse Biosciences is not included in the S&P 500 index

Is Pulse Biosciences in the NASDAQ 100?

No, Pulse Biosciences is not included in the NASDAQ 100 index

Is Pulse Biosciences in the Dow Jones?

No, Pulse Biosciences is not included in the Dow Jones index

When was Pulse Biosciences's last earnings report?

Pulse Biosciences's most recent earnings report was on Oct 30, 2024

When does Pulse Biosciences report earnings?

The next expected earnings date for Pulse Biosciences is Mar 28, 2025

Should I buy Pulse Biosciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions